Dana Investment Advisors, Inc. - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 104 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
Dana Investment Advisors, Inc. ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$4,000
-63.6%
65,0000.0%0.00%
-100.0%
Q2 2022$11,000
-64.5%
65,0000.0%0.00%0.0%
Q1 2022$31,000
-16.2%
65,0000.0%0.00%
-50.0%
Q4 2021$37,000
-65.7%
65,0000.0%0.00%
-60.0%
Q3 2021$108,000
-0.9%
65,0000.0%0.01%0.0%
Q2 2021$109,000
-0.9%
65,0000.0%0.01%0.0%
Q1 2021$110,000
+6.8%
65,0000.0%0.01%0.0%
Q4 2020$103,000
+66.1%
65,0000.0%0.01%
+66.7%
Q3 2020$62,000
+51.2%
65,0000.0%0.00%
+50.0%
Q2 2020$41,000
+51.9%
65,0000.0%0.00%0.0%
Q1 2020$27,00065,0000.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Empery Asset Management, LP 4,262,409$2,430,0005.07%
CVI Holdings, LLC 5,171,896$2,948,0000.20%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$534,0000.18%
CVA Family Office, LLC 1,137,920$649,0000.16%
ACT CAPITAL MANAGEMENT, LLC 291,500$166,0000.12%
Cypress Capital Management LLC (WY) 196,775$112,0000.09%
Willis Investment Counsel 2,181,840$1,244,0000.06%
NTB Financial Corp 146,100$83,0000.06%
Helen Stephens Group, LLC 117,222$67,0000.05%
SRS Capital Advisors, Inc. 629,172$359,0000.05%
View complete list of AMPIO PHARMACEUTICALS INC shareholders